Are Me-Too Drugs Cheaper? A Look at Pricing and Patient Costs
•
5 min read
According to a 2016 study published in *Health Affairs*, Medicare Part D patients paid average copayments more than 10 times higher for certain brand-name “me too” medications compared to their generic therapeutic alternatives. This stark statistic highlights the complex and often counterintuitive pricing of me too drugs within the pharmaceutical marketplace.
